Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Cesano

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2012
Single-cell network profiling of peripheral blood mononuclear cells from healthy donors reveals age- and race-associated differences in immune signaling pathway activationDiane M Longo, Brent Louie, Santosh Putta, et al.
Plos One|January 11, 2021
CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanomaArjun Khunger, Erin Piazza, Sarah Warren, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 10, 2013
Single cell network profiling assay in bladder cancerTodd M Covey, Manish A Vira, Matt Westfall, et al.
Plos One|February 23, 2013
Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational statusAlessandra Cesano, Santosh Putta, David B Rosen, et al.
Cytometry. Part B, Clinical Cytometry|February 16, 2012
Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readoutsAlessandra Cesano, David B Rosen, Pat O'Meara, et al.
Journal for Immunotherapy of Cancer|November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerationsKevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer|November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationGiuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Journal for Immunotherapy of Cancer|April 11, 2019
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trialXiaotong Li, Sarah Warren, Vasiliki Pelekanou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2003
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphomaJohn P Leonard, Morton Coleman, Jamie C Ketas, et al.
Plos One|January 16, 2013
AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicinDavid B Rosen, Kimberly H Harrington, James A Cordeiro, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2012
Single-cell network profiling of peripheral blood mononuclear cells from healthy donors reveals age- and race-associated differences in immune signaling pathway activationDiane M Longo, Brent Louie, Santosh Putta, et al.
Plos One|January 11, 2021
CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanomaArjun Khunger, Erin Piazza, Sarah Warren, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 10, 2013
Single cell network profiling assay in bladder cancerTodd M Covey, Manish A Vira, Matt Westfall, et al.
Plos One|February 23, 2013
Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational statusAlessandra Cesano, Santosh Putta, David B Rosen, et al.
Cytometry. Part B, Clinical Cytometry|February 16, 2012
Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readoutsAlessandra Cesano, David B Rosen, Pat O'Meara, et al.
Journal for Immunotherapy of Cancer|November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerationsKevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer|November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationGiuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Journal for Immunotherapy of Cancer|April 11, 2019
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trialXiaotong Li, Sarah Warren, Vasiliki Pelekanou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2003
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphomaJohn P Leonard, Morton Coleman, Jamie C Ketas, et al.
Plos One|January 16, 2013
AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicinDavid B Rosen, Kimberly H Harrington, James A Cordeiro, et al.
Pageof 9